과제정보
연구 과제 주관 기관 : Chungbuk National University
참고문헌
- Rutherford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD. Chronic progressive renal disease: rate of change of serum creatinine concentration. Kidney Int 1977;11:62-70. https://doi.org/10.1038/ki.1977.8
- Fornoni A. Proteinuria, the podocyte, and insulin resistance. N Engl J Med 2010;363:2068-2069. https://doi.org/10.1056/NEJMcibr1008395
- Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007;56:2155-2160. https://doi.org/10.2337/db07-0019
- Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005;16:1733-1741. https://doi.org/10.1681/ASN.2005020159
- Zheng M, Lv LL, Ni J, et al. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One 2011;6:e20431. https://doi.org/10.1371/journal.pone.0020431
- Asanuma K, Yanagida-Asanuma E, Faul C, Tomino Y, Kim K, Mundel P. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol 2006;8:485-491. https://doi.org/10.1038/ncb1400
- Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008;14:931-938. https://doi.org/10.1038/nm.1857
- Pugliese G. Updating the natural history of diabetic nephropathy. Acta Diabetol 2014;51:905-915. https://doi.org/10.1007/s00592-014-0650-7
- Jim B, Ghanta M, Qipo A, et al. Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One 2012;7:e36041. https://doi.org/10.1371/journal.pone.0036041
- Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-860. https://doi.org/10.1056/NEJMoa011303
- Byun JM, Lee CH, Lee SR, et al. Renal outcomes and clinical course of nondiabetic renal diseases in patients with type 2 diabetes. Korean J Intern Med 2013;28:565-572. https://doi.org/10.3904/kjim.2013.28.5.565
피인용 문헌
- Proteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach vol.5, pp.None, 2016, https://doi.org/10.3389/fmed.2018.00221
- Podocyturia: why it may have added value in rare diseases vol.12, pp.1, 2019, https://doi.org/10.1093/ckj/sfy081
- Change in Renal Glomerular Collagens and Glomerular Filtration Barrier-Related Proteins in a Dextran Sulfate Sodium-Induced Colitis Mouse Model vol.20, pp.6, 2016, https://doi.org/10.3390/ijms20061458
- A novel splicing variant of small nucleolar RNA host gene 4 is a podocyte-selective non-coding RNA upregulated in response to puromycin aminonucleoside-induced podocyte injury vol.165, pp.5, 2019, https://doi.org/10.1093/jb/mvy118
- Immunochromatographic assay to detect α‐tubulin in urine for the diagnosis of kidney injury vol.34, pp.1, 2016, https://doi.org/10.1002/jcla.23015
- Spatio-temporal patterning of different connexins in developing and postnatal human kidneys and in nephrotic syndrome of the Finnish type (CNF) vol.10, pp.None, 2016, https://doi.org/10.1038/s41598-020-65777-5
- A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies vol.49, pp.5, 2016, https://doi.org/10.1177/0192623320985045
- Urinary podocyte markers in kidney diseases vol.523, pp.None, 2021, https://doi.org/10.1016/j.cca.2021.10.017